Assessment of diffuse myocardial fibrosis by using MR imaging in asymptomatic patients with aortic stenosis

Radiology

Volumn 274, Issue 2, 2015, Pages 359-369

  Lee, Seung Pyo ^a   Lee, Whal ^a   Lee, Joo Myung ^a   Park, Eun Ah ^a   Kim, Hyung Kwan ^a   Kim, Yong Jin ^a   Sohn, Dae Won ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAXATION TIME; SYMPTOMATOLOGY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VERY ELDERLY; AORTA VALVE STENOSIS; ASYMPTOMATIC DISEASE; CARDIAC IMAGING; COMPLICATION; EVALUATION STUDY; FIBROSIS; HEART MUSCLE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASES; CARDIAC IMAGING TECHNIQUES; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PROSPECTIVE STUDIES;

EID: 84921722475     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14141120     Document Type: Article

References (33)

1. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107(7):984-991.
2. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79(4):744-755.
3. Milano AD, Faggian G, Dodonov M, et al. Prognostic value of myocardial fbrosis in patients with severe aortic valve stenosis. J Tho-rac Cardiovasc Surg 2012;144(4):830-837.
4. Azevedo CF, Nigri M, Higuchi ML, et al. Prognostic signifcance of myocardial f-brosis quantifcation by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 2010;56(4):278-287.
5. Weidemann F, Herrmann S, Störk S, et al. Impact of myocardial fbrosis in patients with symptomatic severe aortic stenosis. Circulation 2009;120(7):577-584.
6. Dweck MR, Joshi S, Murigu T, et al. Mid-wall fbrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58(12):1271-1279.
7. Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL. Losartan-dependent regression of myocardial fbrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105(21):2512-2517.
8. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fbrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57(8):891-903.
9. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83(6):1849-1865.
10. Kang DH, Park SJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010;121(13):1502-1509.
11. Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010;121(1):151-156.
12. Filett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fbrosis: preliminary validation in humans. Circulation 2010;122(2):138-144.
13. Ugander M, Oki AJ, Hsu LY, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 2012;33(10):1268-1278.
14. Iles L, Pfuger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fbrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52(19):1574-1580.
15. Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fbrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Ra-diol 2008;43(2):141-144.
16. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114(5): e84-e231.
17. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22(1): 1-23; quiz 101-102.
18. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantif-cation: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantifcation Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18(12):1440-1463.
19. Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 2004;17(6):630-633.
20. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008; 10:35.
21. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modifed Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52(1):141-146.
22. Bull S, White SK, Piechnik SK, et al. Human non-contrast T1 values and correlation with histology in diffuse fbrosis. Heart 2013;99(13):932-937.
23. Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hyper-trophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6(4):475-484.
24. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Car-diovasc Imaging 2013;6(4):488-497.
25. Roujol S, Weingärtner S, Foppa M, et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 2014;272(3): 683-689.
26. Villari B, Vassalli G, Monrad ES, Chiariello M, Turina M, Hess OM. Normalization of dia-stolic dysfunction in aortic stenosis late after valve replacement. Circulation 1995;91(9): 2353-2358.
27. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011; 32(6):670-679.
28. Heymans S, Schroen B, Vermeersch P, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fbrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005;112(8):1136-1144.
29. Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004;44(8): 1609-1618.
30. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF. Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 2008;29(10): 1283-1289.
31. Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively Influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 2006;47(11): 2229-2236.
32. Liu CY, Liu YC, Wu C, et al. Evaluation of age-related interstitial myocardial fbrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2013;62(14):1280-1287.
33. Falcão-Pires I, Hamdani N, Borbély A, et al. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardio-myocyte stiffness. Circulation 2011;124(10): 1151-1159.